Pharmacist Medication Insights: for Panzyga for Primary Humoral Immunodeficiency

Panzyga (immune globulin intravenous [Human]-ifas) is indicated for the following:

• For the treatment of adults 18 years of age and older with chronic inflammatory demyelinating polyneuropathy (CIDP) to improve neuromuscular disability and impairment.
• Primary humoral immunodeficiency (PI) in patients 2 years of age and older.
• Chronic immune thrombocytopenia (ITP) in adults.